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Theglomerulardamageduring the earlyphase ofthepassive antiglomerularbase-
ment membrane (GBM)' nephritis, a well-known model ofexperimental renal dis-
ease, is dependent on complement and polymorphonuclear granulocytes (PMN) in
most animal species studied (1-3). Recently we have described a murine model of
anti-GBM nephritis, inwhichthe massive albuminuriaoccurring after theinjection
ofheterologous antibody is not mediated by complement, but iscompletely depen-
dent on the presence ofPMN in the glomeruli (4). Lysosomal proteinases and reac-
tive oxygen metabolites (ROM) from activated PMN, acting either alone or syner-
gistically, have been implicated as agents contributing to the glomerularinjury and
enhanced permeability for proteins (5-12). Activated PMN secrete lysosomal en-
zymes, especially when they are firmly attached to extracellular matrices (8-10, 13,
14). It has been established that neutral proteinases are major factors in tissue de-
struction at sites ofinflammation. These enzymes can cleave many ifnot all of the
constituents ofthe extracellular matrix, includingthe GBM(13-17). Not onlylysosomal
proteinasesbut also ROM, generatedduring arespiratoryburstfrom activated PMN,
can function as mediators of tissue injury (16, 18, 19). Several in vitro and in vivo
studies have reported the participation of ROM in neutrophil-dependent glomer-
ular disease (6, 7, 11, 12, 17). ROM have been shown to degrade GBM in vitro in
concert with lysosomal proteinases, although others could not confirm this syner-
gistic effect (20-22). In most experiments the evidence of their mediator function
ofglomerular injury is largely derivedfrom the inhibitory effectsofROM scavengers
on the damage produced by PMN (5-7, 17, 23).
To examine more precisely the role ofleukocytic neutral proteinases, we induced
an anti-GBMnephritis inC57BL/6J,bg/bg (beige)micewith a geneticdefect analo-
gous to the Chediak-Higashi syndrome in man, in which PMN are reported to be
deficient for elastase and cathepsin G(24, 25). The severe albuminuria after injec-
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tions of anti-GBM antibodies in normal control mice, did not occur in this partic-
ular beige mouse strain, despite the presence of a comparable influx of PMN in
the glomeruli. Since the in vitro superoxide production of PMN from beige mice
was normal, it is concluded that leukocytic neutral proteinases are responsible for
the GBM damage that leads to albuminuria in this model. Furthermore, results of
inhibitory studies with ROM scavengers in anti-GBM nephritis induced in B10 .D2
new mice suggest that ROM do not participate in the induction of the albuminuria
in this model.
Materials and Methods
Reagents.
￿
The following materials were obtained from the indicated sources: catalase (Sigma
Chemical Co., St . Louis, MO); PMSF, cetrimide, and PMA (Sigma Chemical Co.); desferri-
oxamine mesylate (DFO) (Ciba-Geigy, Basel, Switzerland); methoxysuccinyl-alanyl-alanyl-
propyl-valyl-aminomethylcoumarin (Bachem, Bubendorf, Switzerland); FITC (BDH, Poole,
UK); FITC-labeled swine anti-rabbit Ig, and FITC-labeled rabbit anti-human fibrinogen
(Dako Corp., Copenhagen, Denmark); FITC-labeled goat anti-mouse IgG (heavy and light
chains), and FITC-labeled goat anti-mouse C3 (Cappel Laboratories, West Chester, PA);
glutaraldehyde (LADD, Burlington, VT); sodium cacodylate and lead citrate (BDH Chem-
icals Ltd.); osmium tetroxide (0804) (Johnson Matthey Chemicals Ltd., Roystone, UK);
IFA (Difco Laboratories, Detroit, MI); hematoxylin, eosin, Epon 812, and uranyl acetate
(Merck, Darmstadt, FRG); paraplast (Amstelstad, Amsterdam, The Netherlands); Sepharose
4B-coupled protein-A (Pharmacia, Uppsala, Sweden); XM-50 diaflow membrane (Amicon
Corp., Scientific System Division, Lexington, MA); Dulbeccds PBS (Flow Laboratories, Ir-
vine, Scotland).
Animals.
￿
C57BL/6J,bg/bg (beige), C57BL/6J,+/+ (control) and B10.D2 new mice were
originally obtained from TheJackson Laboratory (Bar Harbor, ME). Only male mice were
used at ages of3-4 mo. Randomly bred Swiss mice were purchased from the Central Institute
for the Breeding of Laboratory Animals, TNO, Zeist, The Netherlands. Rabbits, used for
the preparation of the antiserum, were bought from a local breeder.
Production of Anti-mouse GBMAntibodies.
￿
GBM was prepared from Swiss mouse kidneys
by a differential sieve technique, followed by sonication and detergent treatment as previ-
ously described (26, 27). Antisera against this basement membrane suspension were raised
in rabbits. The pooled antisera were heated at 56'C for 45 min and the IgG fractions were
purified by affinity chromatography on a Sepharose 4B-coupled protein-A column. The IgG
antibodies were concentrated by ultrafiltration with an XM-50 Diaflow membrane, sterilized
by passage through a sterile 0.2-lim filter and stored at -30'C. The IgG concentration was
measured by the radial immunodiffusion technique (28).
Induction ofAnti-GBMNephritis.
￿
Anti-GBM nephritis in the mouse was induced by intra-
venous injection of rabbit anti-mouse GBM (RaM-GBM) antibodies, as described previ-
ously (4, 26). A dose-response study was performed in C57BL/6J,bg/bg (beige) and
C57BL/6J,+/+ (control) mice that received increasing amounts (1.4-22 mg) of RaM-GBM
antibodies. Albuminuria, as a sign ofglomerular protein leakage, was measured in 18-h urine
samples collected 1 d before, and between 6 and 24 h after the injection of the RaM-GBM
antiserum. During their confinement in individual metabolic cages the mice received only
tap water ad lib. Pathological albuminuria was defined as a value greater than the normal
mean plus two standard deviations. Urinary albumin concentrations were measured by radial
immunodiffusion in 18-h urine samples, using a goat antiserum against mouse albumin (27).
The kidneys of four mice, killed at 2 and 24 h after injection of 2.8 and 11 mg of the anti-
GBM serum, were processed for histological examinations.
Isolation ofPeritoneal PMN.
￿
Mouse peritoneal cells were elicited by injection of 0.5 ml i.p.
of IFA in beige and control mice. After 24 h the cells were harvested by lavaging the perito-
neal cavity with ice-cold saline. The cell suspension, containing >90% of PMN, was washed
twice in saline and resuspended in Dulbeccds PBS when used for the determination of su-
peroxide production. For the measurement of the elastase activity, the cells were disruptedSCHRIJVER ET AL.
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by sonication in 0.5 M NaCl, 0.4% cetrimide, 0.1 M Tris, pH 8.0, as described before (PMN
extract) (29).
Superoxide Production andElastaseActivityfrom IsolatedPMN .
￿
The superoxide production by
peritoneal PMNs (106/ml) was determined upon stimulation with 100 ng/ml PMA in Dul-
becco's PBS at 37°C for 15 min. Superoxide dismutase inhibitable cytochrome c reduction
was measured as described before (30), assuming an extinction coefficient of 21,000/M/cm
(difference between reduced and oxidized form). The rate of superoxide production is ex-
pressed as nmol cytochrome c reduced per minute per 106 cells. To confirm the reported
deficiency of leukocytic neutral proteinases, we measured the elastase activity from the iso-
lated peritoneal PMN fluorimetrically using methoxysuccinyl-alanyl-alanyl-prolyl-valyl-
aminomethylcoumarine as a substrate (31). The enzyme content of the PMN is expressed
as pkatal per 106 cells, 1 pkatal being the amount of enzyme that converts 1 pmol of sub-
strate per second under the given assay conditions.
Degradation of GBMby PMNExtracts.
￿
GBM from mouse kidneys (2 mg/ml) was labeled
with 0.5 mg/ml FITC for 6 h at 37°C, yielding a preparation of -1.6 kg FITC per milligram
GBM. Breakdown ofGBM-FITC was measured as follows: 50 A,1 of GBM-FITC (2 mg/ml)
suspended in phosphate buffer (pH 7.4) was added to 50 tcl of a PMN extract (107 cells/ml,
pool of five mice). The mixture was incubated at 37°C for 60 min, 1 ml phosphate buffer
was added, and after centrifugation (5 min, 10,000 g) the amount of solubilized GBM in
the supernatant was measured fluorimetrically at 488 nm (excitation) and 520 nm (emis-
sion). Maximum fluorescence was determinedby exhaustive trypsinisation ofthe GBM-FITC
preparation. Degradation of GBM by PMN extracts was expressed as a percentage of the
total fluorescence. PMSF, a serine proteinase inhibitor, was added at 1 mM to the PMN
extracts for 60 min, before the incubation with GBM-FITC.
Efect of Catalase andDesferrioxamine on Albuminuria in BIO.D2 New Mice.
￿
Thymol-free bo-
vine catalase, which converts H202 to 02 and H20, was obtained in a crystalline form con-
taining 11,000 U/mg. 10 mg of catalase was injected intravenously together with 5.3 mg of
antibodies in B10.D2 new mice. The iron chelator desferrioxamine mesylate was dissolved
in distilled water at a final concentration of 75 mg/ml. B10.D2 new mice received 7.5 mg
s.c. and 2.5 mg i.v of DFO before the administration of 5.3 mg of antibodies. Albuminuria
was measured as described before. Morpholical studies were done on kidneys of mice killed
2 h after the administration of antibody.
Light Microscopy, Immunofluorescence, andElectron Microscopy.
￿
Kidney fragments were fixed
in Bouin's solution, dehydrated, and embedded in paraplast (Amstelstad, Amsterdam, The
Netherlands) and 4-/Am sections were stained with hematoxylin and eosin, Periodic Schiff
and Silver methenamine, as mentioned earlier (27). The glomerular influx of PMNs was
determined by counting ofPMNs in at least40 glomeruli per mouse in four mice per obser-
vation point, and expressed as the average number of PMN per glomerulus. For im-
munofluorescence, kidney fragments were snap frozen in liquid nitrogen, and 2-J.m cryostat
sections were stained with FITC-labeled swine anti-rabbit IgG, goat anti-mouse IgG (heavy
and lightchains), and C3, and rabbit anti-human fibrinogen, which crossreacts with mouse
fibrinogen. The sections were examined in a Leitz fluorescence microscope equipped with
a Ploemopak epiillumination and the staining intensity was recorded semiquantitatively (on
a scale from 0 to 4+) as described before (27). For electron microscopy small pieces of cortex
were fixed in 2.5% glutaraldehyde dissolved in 0.1 M sodium cacodylate buffer, pH 7.2, for
4 h at 4°C, and washed in the same buffer. The tissue fragments were postfixed in phosphate-
buffered 2% Os04 for 2 h, dehydrated, and embedded in Epon 812. Ultrathin sections were
cut in an ultratome (LKP Produkter, Bromma, Sweden) and stained with 5% uranyl acetate
for 45 min and with lead citrate for 2 min at room temperature. The sections were examined
in an electron microscope (ELMISKOP 101; Siemens, Berlin, FRG).
Statistical Analysis.
￿
For statistical analysis, Wilcoxon's rank sum test was used. p values
<0.05 were regarded as significant. All values are expressed as means t SD.
Results
Albuminuria.
￿
Previous studies have shown that the early phase of anti-GBM
nephritis in C57BL/10, B10.D2 new, and B10.D2 old mice is characterized by a dose-1438
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TABLE I
Albuminuria in C57BL/6j, bg/bg and C57BL/6j, + /+ Mice
at Day I after the Intravenous Injection ofRaM-GBM
" Number of mice in parentheses .
2 Significantly different from C57BL/6J, + / + (p < 0.01) .
5 Significantly different from untreated C57BL/6J,bg/bg mice, (p < 0.02) .
dependent albuminuria, that is at its maximum 24 h after administration of anti-
body (4, 26) . This albuminuriadevelops after atransient glomerular influx ofPMN
during the first hours . Table I shows that doses ofRaM-GBM antibody ranging
from 2 .8 to 22 mg induced an albuminuria in control C57BL/6J,+/+ mice that
was related to the amount of antibody given . By contrast, the albuminuria of
C57BL/6J,bg/bg mice was not significantly different from the physiological al-
buminuria at nearly all doses of antibody used . Only at the highest antibody dose
of 22 mg was the albuminuria in beige mice significantly higher than that in un-
treated animals of the same strain (p < 0.02). Table I also shows that the physiolog-
FIGURE 1 .
￿
Detection of rabbit Ig (A) and mouse C3 (B) by direct immunofluorescence at 2 h
after injection of 5 .3 mg ofRaM-GBM antibody into a C57BL/6j,bg/bg mouse . Rabbit Ig is
localized in a strong linear pattern along the GBM (A), whereas mouse C3 is distributed in a
more fine granular pattern (B) . (A) x 160, (B) x 200 .
Dose of RaM-GBM
Albuminuria
C57BL/6J,bg/bg C57BL/6J, + / +
mg tcgl18 h
1.4 61 t 26 (5)" 63 ± 23 (5)
2 .8 78 t 41 (5)1 344 t 87 (6)
5 .5 64 t 15 (5)1 1,634 ± 713 (6)
11 144 t 95 (6)1 4,747 ± 1,548 (6)
22 434 ± 414 (6)25 7,913 t 3,989 (6)
None 112 t 90 (24)1 51 * 23 (30)SCHRIJVER ET AL.
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TABLE II
Immunofluorescence Findings in C57BLl6J, bglbg Mice
2 h after Injection ofRaM-GBM
Dose
￿
Rabbit IgG'
￿
Mouse C31
￿
Fibrin
mg
2.8
￿
+ + +
￿
+
￿
-
11
￿
++++
￿
++/+++
￿
-/+
Identical results were obtained in C57BL/6J,+/+ control mice .
' Linear staining .
1 Fine granular staining along the capillary walls .
ical albumin excretion in untreated beige mice was slightly, but significantly, higher
than that of normal control mice .
Histology.
￿
We studied the glomerular inflammatory response in beige and con-
trol mice by injecting a low dose (2.8 mg) and a high dose (11 mg) ofRaM-GBM
antibody. By immunofluorescence the two mouse strains showed comparable linear
binding of rabbit Ig (Fig. 1 A), and a fine granular binding of the third component
of the complement system to the glomerular capillary wall (Fig . 1 B and Table II) .
As in our previous studies, the amount ofmouse C3 was greatly diminished after
24 h, while at that time small fibrin deposits hadappeared in some glomerular loops .
2 h after injection of the antibodies a massive glomerular influx ofPMNs was seen,
the number ofwhichwasrelated to the dose of antibody (Fig . 2) . Beige mice showed
a more prominent influx ofPMN in their glomeruli than control mice, especially
at the lowdose of antibody (Table III) . 24h afterthe injection ofantibody thenumber
of intraglomerularPMN had returned to normal values in both groups . The glo-
merular changes at 2 h were studied in more detail by electron microscopy. In both
FIGURE 2 .
￿
Aprominent influx
of polymorphonuclear granulo-
cytes (avows) is seen in a glomer-
ulusofa C57BL/6J,bg/bg mouse
by light microscopy at 2 h after
injection of 5 .3 mg of RaM-
GBM antibody (Periodic Schiff
staining, x 210) .1440
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TABLE III
Influx of PMN in the Glomeruli 2 h after Intravenous
Injection of RaM-GBM
PMN per glomerulus'
PMN in 40 glomeruli per mouse were counted. The number is expressed as
the mean t SD of PMN per glomerulus of four mice per experimental group.
strains of mice PMN were observed, either lying free in the glomerular capillary
lumina, ormaking contacts ofvaryingextent with the innerside ofthe GBM, pushing
aside or damaging the endothelial cells (Fig. 3). In some glomerular loops, PMN
were seen makingcontact with the GBM through long pseudopods penetratingthe
endothelial fenestrae (Fig. 4); at other sites PMN were lying in close apposition to
adenuded GBM. Occasionally, a few platelets were also seen attached to the GBM.
Endothelial cells more remote from the sites ofGBM-fixed PMN had a normal ap-
pearance or were swollen and detached from the underlying basement membrane.
Electron densedeposits or fibrin fibrilswere notobserved at this stage ofthe disease.
Thus, despitethe absence ofalbuminuriain beige mice, comparable damage ofen-
dothelial cells was noted with PMN lying in close contact to the GMB.
Superoxide Production, Elastase Content, and GBM-degrading Capacity ofPeritoneal PMN.
Since differences in ROM released from activated PMNs could theoretically also
explain the observed difference in albuminuriabetween normal and beige mice, we
measured the superoxide production of peritoneal PMNs in both strains. In addi-
tion, we measured the elastase content of peritoneal PMNs in order to verify the
reported deficiency ofneutral proteases in the beige mice (24). Table IV shows that
PMA-induced superoxide production ofbeige PMNs is not significantly different
from that in normal mice. We could confirm the deficiency o£ neutral proteinases
in the beige mice. The elastase content was shown to be sixfold lower as compared
with normal C57BL/6 mice.
The capacity ofPMN-extracts ofboth strains to degrade purified murine GBM
fragments is shown in Table V. FITC-labeled, insoluble GBM was readily broken
down by a PMN-extract from control mice, whereas the extracts from beige PMN
were significantly less effective. Pretreatment ofthe PMN extracts ofbeigeand con-
trol mice with 1 mM ofthe serine proteinase inhibitor PMSFcompletely prevented
the breakdown of GBM, indicating that the enzymes involved belong to the class
of serine proteinases.
Effects of ROM Scavengers on Albuminuria in B10.D2 New Mice.
￿
As shown in the
previous section, superoxide production bybeige mice wasnot significantly different
from control mice, suggesting that ROM are not responsible for the difference in
glomerular injury between the two strains. It is, however, still possible that ROM
are involved ininducing theobserveddamage, by acting synergisticallywith neutral
RaM-GBM C57BL/6J,bg/bg C57BL/6J,+/+
mg
2.8 7 .2 t 4.8 3.2 t 1 .5
11 9 .1 t 1 .0 7.9 f 2 .8
None 0.2 t 0.1 0.1 ± 0.1SCHRIJVER ET AL .
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FIGURE 3 .
￿
Electron photomicrograph ofaglomerular capillary loop ofa C57BL/6J,bg/bg mouse
at 2 h after administration of 2.8 mg ofRaM-GBM antibody showing two polymorphonuclear
granulocytes (PMN) in the capillary lumen . One of thePMN is directly attached to the inner
side of theGBM (arrowheads) replacing the endothelium . The other PMN containing a giant
lysosome (asterisk) in its cytoplasm lies against an intact endothelial layer. Identical results were
seen in C57BL/6J,+/+ (control) mice injected with the same amount ofRaM-GBM antibody
(x 16,640) . Abbreviations : US, urinary space ; Ep, foot processes of the visceral epithelial cell ;
Cap, capillary lumen .
proteases . To investigate the possible role ofROM, we tested the effect of scavengers
of hydrogen peroxide andhydroxyl radicals in ouroriginal anti-GBM nephritis model
in B10.D2 newmice . Neither catalase, which eliminates hydrogen peroxide, nor DFO,
which chelates iron and thereby prevents hydroxyl radical formation, were able to
prevent albuminuria in anti-GBM nephritis, as shown in Table VI .1442
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FIGURE 4 .
￿
Electron photomicrograph ofa glomerular capillary loop ofa C57BL/6J,bg/bg mouse
2 h after administration of 2 .8 mg ofRaM-GBM antibody. The endothelial cell (End) has been
partly pushed aside by aPMN, that adheres directly to the denuded surface oftheGBM . Pseu-
dopods of the samePMN also make contact with theGBM through endothelial fenestrae (arrow-
head) . The endothelial cell layer between these two points of contact is intact (x 15,300) . Abbrevi-
ations : US, urinary space ; Ep, foot processes ofthe visceral epithelial cell ; Cap, capillary lumen.
TABLE IV
Superoxide Production and Proteinase Content ofPMNfrom
C57BLl6,J,bglbg and C57BLl6,J, +/+ Mice
C57BL/6J,bg/bg
￿
C57BL/6J, + / +
Superoxide production*
(nmol/10 6/min)
￿
3 .4 f 0 .5
￿
2 .9 f 0.7
Elastase (pKatal/106)$ ￿6 t 1
￿
37 f 5
* Figures represent means t SD of six mice .
I Figures represent the results of separate measurements on three pools of five
peritoneal exudates .
TABLE V
Degradation of GBM by PMN Extractsfrom C57BLl6J, bglbg
and C57BLl6J, +/+ Mice
* Number of experiments in parentheses .
t Significantly different from degradation by normal PMN, (p < 0.01) .
§ Significantly different from degradation by normal PMN without PMSF (p
< 0 .01) .
PMN extract
obtained from : Treatment Degradation ofGBM
Buffer - 3 ± 2 (4)*
Beige mice - 10 ± 5 (4)t
Control mice - 34 ± 13 (6)
Beige mice PMSF 4 t 2 (4)
Control mice PMSF 4 ± 2 (6)4SCHRIJVER ET AL.
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TABLE VI
Effect of Inhibitors of Reactive Oxygen Metabolites on Albuminuria in
Anti-GBM Nephritis in B10.D2 New Mice
10 mg ofcatalase were injected intravenously along with the anti-GBM anti-
bodies. DFO was given subcutaneously (7 .5 mg) and intravenously (2.5 mg)
before the administration of the antibodies.
l Albumin excretion measured on urine samples obtained from 6-24 h after in-
jection of the antibodies. Number of mice examined in parentheses.
Discussion
The data presented in this paperdemonstrate the involvement of leukocytic neu-
tral proteinases in the induction of albuminuriaduring the acute phaseof anti-GBM
nephritis in the mouse. It is shown that mice deficient in leukocyte elastase do not
exhibit significant albuminuria in the early phase of anti-GBM nephritis compared
with normal mice, notwithstanding an identical glomerular infiltration of PMN in
both groups. Surprisingly, electron microscopy showed many PMNs attached to the
denuded inner side of the GBM concomitant with damage to endothelial cells in
both strains of mice. These results suggest that unlike the findings in other models
with endothelial injury (32, 33), glomerular endothelial damage perse does not lead
to an enhanced glomerular permeability for proteins. Other mediators than neutral
proteinases seem to be responsible forthe destruction of the endothelia. This is sup-
ported by recent observations in rat kidneys, where perfusion with elastase and
cathepsin G led to proteinuria without any visible injury of endothelial cells (34).
No definite role of ROM, the generation of which is not inhibited in PMN of beige
mice, was found in the induction of albuminuria in this model, although they may
have been involved in the observed cell injury. In vitro studies have demonstrated
that ROM are indeed directly cytotoxic to a wide variety of normal cells including
endothelial cells (35).
Several ROM have been implicated in the induction ofPMN-dependent glomer-
ular disease in rats, such as hydrogen peroxide, hydroxyl radicals, and hypohalous
acid, the toxic derivatives of the reaction of the leukocytic myeloperoxidase with
hydrogen peroxide (5, 6, 11, 12). The evidence of their action is largely based on
the effects of ROM scavengers on the glomerular injury by circulating PMN. In
our murine model the albuminuria was not inhibited by catalase, which catalyzes
the conversion of hydrogen peroxide to water and oxygen, nor by the iron chelator
DFO, which prevents the generation of hydroxyl radicals from hydrogen peroxide.
Equivalent dosages of their agents in rats have been shown to be highly effective
(6). Whether this discrepancy is caused by differences in effector mechanisms be-
tween rats and mice, or by insufficient delivery of the scavengers to the site of action
Inhibitor` RaM-GBM Albuminurial
mg ftg118 h
Catalase 5 .3 2,650 ± 578 (8)
Catalase - 27 ± 21 (6)
DFO 5 .3 2,808 ± 1,626 (6)
DFO - 106 ± 79 (5)
None 5 .3 2,769 t 1,062 (8)1444
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in mice, remains to be investigated. In vitro superoxide production by activated PMN
of beige mice was not significantly different from control values. Recently, it was
shown by others that also hydrogen peroxide production in both strains was similar
(36). They observed, however, a reduced production of hydroxyl radicals in vitro
by PMN of beige mice, a phenomenon that is not easy to explain, since hydroxyl
radicals are derived from hydrogen peroxide, which is produced in equal amounts (36).
Several studies both in man and in experimental animals suggest a role for neutral
proteinases in glomerular damage. It has been shown that lysosomal enzymes from
PMNs, especially elastase and cathepsin G, can digest GBM in vitro (8, 9, 15, 21,
22, 37). In addition, PMN-derived neutral proteinases along with fragments of the
GBM have been detected in the urine of rabbits with a passive anti-GBM nephritis
(8). Both these components have also been found in the urine of patients with a prolifer-
ative glomerulonephritis in which PMN were involved (38). Recently, a linear corre-
lation between urinary excretion of neutral proteinases and proteinuria was found
in a model of accelerated autologous phase anti-GBM nephritis and in aminonucleoside
nephrosis (39). In these latter models, but also in the above-mentioned clinical study,
the neutral proteinases recovered from urine were able to degrade GBM in vitro.
It has also been shown that administration of amidine-type proteinase inhibitors
in vivo protected against glomerular injury during immune complex-mediated glo-
merulonephritis (40). It was suggested that these inhibitors act on proteinases, such
as Hageman factor, kallikrein, plasminogen activator and plasmin, and thereby
dampen the inflammatory response. More direct evidence that neutral serine pro-
teinases can mediate glomerular damage stems from the recent finding that perfu-
sion of rat kidneys with elastase and cathepsin G caused massive proteinuria (34).
The possible role of PMN neutral proteinases has been investigated in several other
models of inflammation. Using the beige mouse as a model, no significant differ-
ences were found in experimental alveolitis, compared with normal mice (41). In
a reversed passive Arthus reaction, used as a model of immune complex vasculitis,
no difference was found in the degree of vascular damage (42). In PMN from humans
with emphysema an enhanced chemotaxis in response to a chemotactic peptide was
found compared with control cells. PMN from patients with bronchiectasis contained
significantly more of the serine proteinase elastase. In both these forms of chronic
obstructive lung disease this "overload" of PMN may have contributed to their greater
extracellular proteolysis (43). These findings illustrate that the role of neutral pro-
teinases might be dependent on the model, i.e., the type of inflammation (tissue lo-
calization), and the animal that is used.
There are several factors that enhance the role of PMN neutral proteinases as
important mediators in glomerular damage. The close apposition of the PMN to
the GBM facilitates not only the binding of released enzymes to it, but may also
exclude plasma proteinase inhibitors such as a-l-proteinase inhibitor and a-l-anti-
chymotrypsin from the site of enzyme action. Binding of elastase to its substrate
is furthermore promoted by virtue of their cationic nature (44). Since this enzyme
has an isoelectric point higher than 8 .8, it will exhibit affinity for the GBM, which
is negatively charged due to the glycosaminoglycan chains of the heparan sulphate
proteoglycans. Affinity of cationic proteins and exclusion of anionic protease inhibi-
tors from GBM might be analogous to the interaction of this protein with negatively
charged cartilage matrix as we have shown before (45, 46).SCHRIJVER ET AL.
￿
1445
We would propose that this particular anti-GBM nephritis model is a useful
screening system for antiproteinase drugs, that ultimately might prove to be effec-
tive in a number of human diseases including pulmonary emphysema, arthritis and
glomerulonephritis.
Summary
Antiglomerular basement membrane (GBM) nephritis with massive albuminuria
can be induced in mice by injection of heterologous antibodiesagainst mouse GBM.
The albuminuria and the glomerular lesions in this model are not mediated by com-
plement, but are dependent on the presence of polymorphonuclear granulocytes
(PMN) in the glomeruli. Neutral serine proteinases and reactive oxygen metabolites
produced by activated PMN have been implicated as agents contributing to tissue
damage. We examined the role of leukocytic neutral proteinases by comparing the
glomerular damage and albuminuria after injection of rabbit anti-mouse GBM an-
tibodies in normal control mice (C57BL/6J,+/+) and in beige mice (C57BL/6J,bg/bg)
in which PMN are deficient of the neutral proteinases elastase and cathepsin G.
The dose-dependent albuminuria that occurred in control mice after injection of
1.4-22 mg of anti-GBM antibodies was not observed in beige mice, despite a com-
parable influx ofPMNs in the glomeruli. By electron microscopy both strains showed
a similar attachment ofPMN to the denuded GBM together with swelling and necrosis
of endothelial cells. Elastase activity of extracts from PMN of beige mice was only
10-15% ofthe activity of control mice. In vitro, GBM degradation by PMN extracts
of beige mice was 70% lower than that seen in control experiments. PMNs of beige
and control mice showed no differences in superoxide production. In addition, ad-
ministration of scavengers of reactive oxygen metabolites, such as catalase and des-
ferrioxamine, did not prevent the albuminuria in this model . These findings sup-
port the important contribution of leukocytic neutral proteinases to the induction
of albuminuria in the acute phase of anti-GBM nephritis in the mouse.
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